Diabetes Report - Dante Labs

Diabetes Report

Regular price €49.00 EUR
/

Please note that these reports are recommended only for Whole Genome Test with 30X and up coverage

(Not compatible with WGL Longreads sequencing test)

 

The Diabetes Report is based on Whole Genome Sequencing Test. As such, it analyzes all Common and Rare Variants associated with Diabetes instead of a limited set of genes, like old genetic target panels. 

Diabetes is a disease that affects your body’s ability to produce or use insulin. 

Along with environmental factors, Genetics plays a key role in the regulation of Diabetes.

 

Click here to see what your report will look like

 

  • 61 genes analyzed
  • 100% genomic regions covered
  • Intragenic and intergenic regions analyzed
  • All variants reported

 

List of genes:

AQP2,AVPR2,CCR5,CTLA4,FOXP3,HLA-DQA1,HLA-DQB1,HLA-DRB1,HNF1A,IL2RA,IL6,INS,ITPR3,OAS1,PTPN22,SUMO4,AVP,ABCC8,ALMS1,ARL6,BBS1,BBS10,BBS12,BBS2,BBS4,BBS5,BBS7,BBS9,BDNF,CEL,CEP290,EIF2AK3,FOXP3,GCK,GLIS3,GNAS,HNF1A,HNF1B,HNF4A,INS,KCNJ11,LEP,LEPR,MAGEL2,MC4R,MKKS,MKS1,NEUROD1,NEUROG3,NTRK2,PCSK1,PDX1,POMC,PTF1A,RFX6,SDCCAG8,SIM1,TRIM32,TTC8,WDPCP,WFS1

We use a cutting-edge form of technology that not even the most advanced hospitals can provide and that allows us to sequenced your entire DNA with unparalleled precision, instead of focusing on only small parts of the DNA. 
Our Sequencing Center is located in L'Aquila, Italy, and with its 900 square-meter fully dedicated to Whole Genome Sequencing is considered Europe's largest private NGS laboratory. 

We perform all our analysis internally and thanks to our high-throughput next generation sequencing (NGS) equipment we guarantee superior quality.

Your sample and data will stay in the European Union (also if you are a US resident) and is protected by the EU General Data Protection Regulation (GDPR). Our technology offers data protection improvements not required by law but considered best practices in the industry.